CooperCompanies Earnings: Slower Growth Ahead?

CooperCompanies, a medical device company, is set to announce its earnings this Thursday. Last quarter, revenue met expectations at $1.06 billion, up 5.7% year-over-year, but future guidance fell short. Analysts predict a 4.2% year-over-year revenue increase to $1.06 billion this quarter, slower than last years 9.8%. Adjusted earnings are expected at $1.12 per share. CooperCompanies has missed revenue estimates four times in the last two years, a concern for investors. In the sector, Boston Scientific saw a 20.3% revenue growth, while Stryker reported a 10.2% increase. Investor sentiment is positive, with share prices up 5.4% over the last month. CooperCompanies shares have risen 9.3% during this period, heading into earnings with an average analyst price target of $83.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.